KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Nektar Therapeutics (NKTR) Profit After Tax (2016 - 2025)

Historic Profit After Tax for Nektar Therapeutics (NKTR) over the last 16 years, with Q3 2025 value amounting to -$35.5 million.

  • Nektar Therapeutics' Profit After Tax rose 414.23% to -$35.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$120.7 million, marking a year-over-year increase of 2826.19%. This contributed to the annual value of -$119.0 million for FY2024, which is 5690.69% up from last year.
  • Nektar Therapeutics' Profit After Tax amounted to -$35.5 million in Q3 2025, which was up 414.23% from -$41.6 million recorded in Q2 2025.
  • In the past 5 years, Nektar Therapeutics' Profit After Tax registered a high of $7.3 million during Q4 2024, and its lowest value of -$159.1 million during Q2 2022.
  • For the 5-year period, Nektar Therapeutics' Profit After Tax averaged around -$74.5 million, with its median value being -$52.4 million (2024).
  • In the last 5 years, Nektar Therapeutics' Profit After Tax tumbled by 5689.88% in 2021 and then surged by 11725.56% in 2024.
  • Quarter analysis of 5 years shows Nektar Therapeutics' Profit After Tax stood at -$145.6 million in 2021, then soared by 59.02% to -$59.7 million in 2022, then rose by 29.5% to -$42.1 million in 2023, then surged by 117.26% to $7.3 million in 2024, then tumbled by 589.22% to -$35.5 million in 2025.
  • Its Profit After Tax stands at -$35.5 million for Q3 2025, versus -$41.6 million for Q2 2025 and -$50.9 million for Q1 2025.